Cargando…
Dipeptidyl peptidase-4 inhibition to prevent progression of calcific aortic stenosis
OBJECTIVE: To evaluate whether the use of dipeptidyl peptidase-4 (DPP-4) inhibitors and their cardiac tissue distribution profile and anticalcification abilities are associated with risk of aortic stenosis (AS) progression. METHODS: Out of the five different classes of DPP-4 inhibitors, two had rela...
Autores principales: | Lee, Sahmin, Lee, Seung-Ah, Choi, Bongkun, Kim, Ye-Jee, Oh, Soo Jin, Choi, Hong-Mi, Kim, Eun Kyoung, Kim, Dae-Hee, Cho, Goo-Yeong, Song, Jong-Min, Park, Seung Woo, Kang, Duk-Hyun, Song, Jae-Kwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677484/ https://www.ncbi.nlm.nih.gov/pubmed/32917732 http://dx.doi.org/10.1136/heartjnl-2020-317024 |
Ejemplares similares
-
Long-term outcomes in distinct phenogroups of patients with primary mitral regurgitation undergoing valve surgery
por: Kwak, Soongu, et al.
Publicado: (2023) -
Echocardiographic aortic valve calcification and outcomes in women and men with aortic stenosis
por: Thomassen, Henrik K, et al.
Publicado: (2017) -
Sex-specific correlates of valvular and arterial calcification burden in patients with moderate aortic stenosis
por: Deslandes, Marianne, et al.
Publicado: (2022) -
Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea
por: Kim, Ju Youn, et al.
Publicado: (2020) -
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
por: Kaiser, Yannick, et al.
Publicado: (2022)